Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ALBIREO PHARMA, INC. | Financial_Report.xls |
| 10-Q - 10-Q - ALBIREO PHARMA, INC. | d31985_10q.htm |
| EX-31.02 - EX-31.02 - ALBIREO PHARMA, INC. | d31985_ex31-02.htm |
| EX-31.01 - EX-31.01 - ALBIREO PHARMA, INC. | d31985_ex31-01.htm |
Exhibit 32.01
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Biodel Inc. (the Company) for the fiscal quarter ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned Errol B. De Souza, President and Chief Executive Officer of the Company and Gary Gemignani, Chief Financial Officer of the Company, each hereby certifies that: (1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: February 12, 2015 | /s/ Errol B. De Souza | ||||
| Errol B. De Souza, President and | |||||
| Chief Executive Officer | |||||
| Dated: February 12, 2015 | /s/ Gary Gemignani | ||||
| Gary Gemignani, | |||||
| Chief Financial Officer |